The New York Entrepreneur

This small-cap stock is expected to take off — if its weight-loss pill trial succeeds

Read Time:9 Second

Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post These tips for investing in mutual funds and ETFs can help you go with the market’s flow
Next post Semtech’s stock pops after sales hike shows business has ‘progressed from stable to growing’